376 related articles for article (PubMed ID: 29137651)
1. Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer's disease.
Bai Y; Li M; Zhou Y; Ma L; Qiao Q; Hu W; Li W; Wills ZP; Gan WB
Mol Neurodegener; 2017 Nov; 12(1):86. PubMed ID: 29137651
[TBL] [Abstract][Full Text] [Related]
2. NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice.
Goussakov I; Miller MB; Stutzmann GE
J Neurosci; 2010 Sep; 30(36):12128-37. PubMed ID: 20826675
[TBL] [Abstract][Full Text] [Related]
3. Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology.
Price KA; Varghese M; Sowa A; Yuk F; Brautigam H; Ehrlich ME; Dickstein DL
Mol Neurodegener; 2014 Oct; 9():41. PubMed ID: 25312309
[TBL] [Abstract][Full Text] [Related]
4. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.
Chabrier MA; Cheng D; Castello NA; Green KN; LaFerla FM
Neurobiol Dis; 2014 Apr; 64():107-17. PubMed ID: 24440055
[TBL] [Abstract][Full Text] [Related]
6. Reduction of Dendritic Inhibition in CA1 Pyramidal Neurons in Amyloidosis Models of Early Alzheimer's Disease.
Ruiter M; Herstel LJ; Wierenga CJ
J Alzheimers Dis; 2020; 78(3):951-964. PubMed ID: 33074225
[TBL] [Abstract][Full Text] [Related]
7. Drebrin in Alzheimer's Disease.
Ishizuka Y; Hanamura K
Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022
[TBL] [Abstract][Full Text] [Related]
8. Evidence for Alzheimer's disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons.
Neuman KM; Molina-Campos E; Musial TF; Price AL; Oh KJ; Wolke ML; Buss EW; Scheff SW; Mufson EJ; Nicholson DA
Brain Struct Funct; 2015 Nov; 220(6):3143-65. PubMed ID: 25031178
[TBL] [Abstract][Full Text] [Related]
9. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
[TBL] [Abstract][Full Text] [Related]
10. Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
Reale M; D'Angelo C; Costantini E; Di Nicola M; Yarla NS; Kamal MA; Salvador N; Perry G
J Alzheimers Dis; 2018; 62(1):467-476. PubMed ID: 29439355
[TBL] [Abstract][Full Text] [Related]
11. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
[TBL] [Abstract][Full Text] [Related]
12. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
[TBL] [Abstract][Full Text] [Related]
13. Synaptotoxicity in Alzheimer's Disease Involved a Dysregulation of Actin Cytoskeleton Dynamics through Cofilin 1 Phosphorylation.
Rush T; Martinez-Hernandez J; Dollmeyer M; Frandemiche ML; Borel E; Boisseau S; Jacquier-Sarlin M; Buisson A
J Neurosci; 2018 Nov; 38(48):10349-10361. PubMed ID: 30341179
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
Howell MD; Bailey LA; Cozart MA; Gannon BM; Gottschall PE
Acta Neuropathol Commun; 2015 Sep; 3():54. PubMed ID: 26337292
[TBL] [Abstract][Full Text] [Related]
15. Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice.
Baglietto-Vargas D; Chen Y; Suh D; Ager RR; Rodriguez-Ortiz CJ; Medeiros R; Myczek K; Green KN; Baram TZ; LaFerla FM
J Neurochem; 2015 Sep; 134(5):915-26. PubMed ID: 26077803
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.
Wang D; Liu X; Liu Y; Li S; Wang C
J Alzheimers Dis; 2017; 59(4):1255-1267. PubMed ID: 28731433
[TBL] [Abstract][Full Text] [Related]
17. Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
Wei C; Zhang W; Zhou Q; Zhao C; Du Y; Yan Q; Li Z; Miao J
Neurochem Res; 2016 Aug; 41(8):1924-38. PubMed ID: 27072684
[TBL] [Abstract][Full Text] [Related]
18. Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain.
Arbel-Ornath M; Hudry E; Boivin JR; Hashimoto T; Takeda S; Kuchibhotla KV; Hou S; Lattarulo CR; Belcher AM; Shakerdge N; Trujillo PB; Muzikansky A; Betensky RA; Hyman BT; Bacskai BJ
Mol Neurodegener; 2017 Mar; 12(1):27. PubMed ID: 28327181
[TBL] [Abstract][Full Text] [Related]
19. Aβ mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease.
Kommaddi RP; Das D; Karunakaran S; Nanguneri S; Bapat D; Ray A; Shaw E; Bennett DA; Nair D; Ravindranath V
J Neurosci; 2018 Jan; 38(5):1085-1099. PubMed ID: 29246925
[TBL] [Abstract][Full Text] [Related]
20. Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease.
Grutzendler J; Helmin K; Tsai J; Gan WB
Ann N Y Acad Sci; 2007 Feb; 1097():30-9. PubMed ID: 17413007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
